Drug
Drug Atrasentan
Drug Atrasentan: highest development phase Phase 3, developed by Novartis. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Novartis
Trials
| Drug | Phase | Indication |
|---|---|---|
| Drug: Atrasentan NCT07498335 | Phase 3 | Berger Disease |
Latest
No recent events.
Follow Drug Atrasentan on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.